Natural killer cells and interferon responses in patients with systemic lupus erythematosus.

Por Tsokos, G C, Rook, A H, Djeu, J Y, Balow, J E
Publicado em 1982

Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary report.

Por Rook, A. H., Heald, P. W., Nahass, G. T., Macey, W., Witmer, W. K., Lazarus, G. S., Jegasothy, B. V.
Publicado em 1989

Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

Por Capocasale, R J, Lamb, R J, Vonderheid, E C, Fox, F E, Rook, A H, Nowell, P C, Moore, J S
Publicado em 1995

Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis.

Por Rook, A. H., Freundlich, B., Nahass, G. T., Washko, R., Macelis, B., Skolnicki, M., Bromley, P., Witmer, W. K., Jegasothy, B. V.
Publicado em 1989

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-...

Por Zhang, Q, Nowak, I, Vonderheid, E C, Rook, A H, Kadin, M E, Nowell, P C, Shaw, L M, Wasik, M A
Publicado em 1996

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Por Rook, A H, Masur, H, Lane, H C, Frederick, W, Kasahara, T, Macher, A M, Djeu, J Y, Manischewitz, J F, Jackson, L, Fauci, A S, Quinnan, G V
Publicado em 1983